ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
2.105
+0.005 (0.24%)
Apr 21, 2026, 9:42 AM EDT - Market open
ProKidney Employees
ProKidney had 231 employees as of December 31, 2025. The number of employees increased by 27 or 13.24% compared to the previous year.
Employees
231
Change (1Y)
27
Growth (1Y)
13.24%
Revenue / Employee
$3,866
Profits / Employee
-$298,641
Market Cap
635.53M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 231 | 27 | 13.24% |
| Dec 31, 2024 | 204 | 41 | 25.15% |
| Dec 31, 2023 | 163 | 76 | 87.36% |
| Dec 31, 2022 | 87 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| CorMedix | 191 |
| Rigel Pharmaceuticals | 174 |
| Prime Medicine | 146 |
| Absci | 140 |
| Kyverna Therapeutics | 130 |
| Ocugen | 116 |
| Adlai Nortye | 109 |
| Aclaris Therapeutics | 73 |
PROK News
- 26 days ago - ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer - GlobeNewsWire
- 3 months ago - ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 months ago - ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates - GlobeNewsWire
- 5 months ago - ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025 - GlobeNewsWire
- 6 months ago - ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference - GlobeNewsWire
- 6 months ago - ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2025 - GlobeNewsWire
- 8 months ago - ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference - GlobeNewsWire
- 8 months ago - ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates - GlobeNewsWire